Table of Contents
1. Hasebe T, Tsuda H, Tsubono Y, Imoto S, Mukai K. Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation. Jpn J Cancer Res 1977;88:590-599.
2. Hasebe T, Imoto S, Ogura T, Mukai K. Significance of basic fibroblast growth factor and fibroblast growth factor receptor protein expression in the formation of fibrotic focus in invasive ductal carcinoma of the breast. Jpn J Cancer Res 1997;88:877-885.
3. Imoto S, Kitaya T, Kodama T, Hasebe T, Mukai K. Idiopathic granulomatous mastitis: case report and review of the literature. Jpn J Clin Oncol 1997;27:274-277.
4. Imoto S. Feasibility of adjuvant chemotherapy for breast cancer patients. Jpn J Clin Oncol, 1997;27:310-315.
5. Imoto S, Mitani F, Enomoto K, Fujiwara K, Ikeda T, Kitajima M, Ishimura Y. Influence of estrogen metabolism on proliferation of human breast cancer. Breast Cancer Res Treat 1997;42:57-64.
Diagnostic Radiology Division
6. Murata S, Satake M, Asato M, Kobayashi H, Eguchi N, Moriyama N. Changes in contrast enhancement of hepatocellular carcinoma and liver: effect of temporary occlusion of a hepatic vein evaluated with spiral CT. Radiology 1997;202:715-720.
7. Ryu M, Shimamura Y, Kinoshita T, Konishi M, Kawano N, Iwasaki M, Furuse J, Yoshino M, Moriyama N. Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol 1997;27:251-257.
8. Iwasaki M, Furuse J, Yoshino M, Moriyama N, Kanemoto H, Okumura H. Spontaneous regression of hepatocellular carcinoma: a case report. Jpn J Clin Oncol 1997;27:278-281.
9. Mori K, Tominaga K, Hirose T, Sasagawa M, Yokoyama K, Moriyama N. Utility of low-dose helical CT as a second step after plain chest radiography for mass screening for lung cancer. J Thorac Imaging 1997;12:173-80.
10. Furuse J, Iwasaki M, Yoshino M, Konishi M, Kawano N, Kinoshita T, Ryu M, Satake M, Moriyama N. Hepatocellular carcinoma with portal vein tumor thrombus: embolization of arterioportal shunts. Radiology 1997;204:787-90.
11. Yokosaki M, Nawano S, Nagai K, Moriyama N, Kodama T, Nishiwaki Y. Cine magnetic resonance imaging, computed tomography and ultrasonography in the evaluation of chest wall invasion of lung cancer. Hiroshima J Med Sci 1997;46:61-66.
12. Ueda J, Takayasu K, Muramatsu Y, Iwata R, Kosuge T, Sakamoto M, Satake M. Pheochromocytoma growing exophytically from right adrenal gland and invaginating into the liver. Jpn J Clin Oncol 1997;27:346-349.
13. Murakami K, Nawano S, Moriyama N, Onuma Y. Usefulness of magnetic resonance imaging with dynamic contrast enhancement and fat suppression in detecting a pancreatic tumor. Jpn J Clin Oncol (in press).
Digestive Endoscopy and Gastrointestinal Oncology Division
14. Yoshida S. Endoscopy. In: Sugimura T, Sasako M, eds. Gastric Cancer. Oxford, New York, Tokyo: Oxford University Press. 1997:168-88.
15. Yoshida S. Endoscopic treatment. In: Sugimura T, Sasako M, eds. Gastric Cancer. Oxford, New York, Tokyo: Oxford University Press. 1997:252-62.
16. Tajiri H, Yokoyama K, Boku N, Ohtsu A, Fujii T, Yoshida S, Sato T, Hakamata K, Hayashi K, Sakata I. Fluorescent diagnosis of experimental gastric cancer using a tumor-localizing photosensitizer. Cancer Lett 1997;111:215-220.
17. Tajiri H. Diagnostic evaluation of pancreatic carcinoma and chronic pancreatitis by pancreatoscopy. Diagn Therap Endosc 1997;3:177-182.
18. Otori K, Oda Y, Sugiyama K, Hasebe T, Mukai K, Fujii T, Tajiri H, Yoshida S, Fukushima S, Esumi H. High frequency of K-ras mutations in human colorectal hyperplastic polyps. Gut 1997;40:660-663.
19. Chin K, Kurashima Y, Ogura T, Tajiri H, Yoshida S, Esumi H. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene 1997;15:437-442.
20. Marotta F, Tajiri H, Li Z. Pure pancreatic juice from patients with chronic pancreatitis has an impaired antibacterial activity. Int J Pancreatol 1997;22:215-220.
21. Marotta F, Reizakovic I, Tajiri H, Safran P, Ideo G. Abstinence-induced oxidative stress in moderate drinkers is improved by bionormalizer. Hepatogastroenterology 1997;44:1360-1366.
22. Muto M, Saito Y, Koike T, Yamagiwa Y, Iijima K, Ikeya S, Sasaki T, Nakayama H, Hoshino E, Sugai Y, Tajiri H, Nishihira T. Primary malignant melanoma of the esophagus with diffuse pigmentation resembling superficial spreading melanoma. Am J Gastroenterol 1997;92:1936-1937.
23. Sugiyama K, Oda Y, Otori K, Kato S, Hasebe T, Fujii T, Tajiri H, Esumi H. Induction of aberrant crypt foci and flat-type adenocarcinoma in the colons of dogs by N-ethyl-NÕ--nitro-N-nitrosoguanidine and their sequential changes. Jpn J Cancer Res 1997;88:934-940.
24. Kondo H, Sugano K, Fukayama N, Hosokawa K, Ohkura H, Ohtsu A, Mukai K, Yoshida S. Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas. Cancer 1997;79:900-905.
25. Ishihama T, Kondo H, Saito D, Yamaguchi H, Shirao K, Yokota T, Hosokawa K, Ono H, Iwabuchi M, Gotoda T, Matsuno Y, Boku N, Ohtsu A, Yoshida S. Clinicopathological studies on coexisting gastric malignant lymphoma and gastric adenocarcinoma: report of four cases and review of the Japanese literature. Jpn J Clin Oncol 1997;27:101-106.
26. Shirao K, Shimada Y, Saito D, Yamao T, Ono H, Yokoyama T, Fukuda H, Oka M, Watanabe Y, Ohtsu A, Boku N, Fujii T, Oda Y, Muro K, Yoshida S. Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancer. J Clin Oncol 1997;15:921-927.
27. Yokota T, Sugano K, Kondo H, Saito D, Sugihara K, Fukayama N, Ohkura H, Ochiai A, Yoshida S. Detection of aberrant crypt foci by magnifying colonoscopy. Gastrointest Endosc 1997;46:61-65.
28. Tajiri H, Kobayashi M, Ohtsu A, Ryu M, Yoshida S. Peroral pancreatoscopy for the diagnosis of pancreatic diseases. Pancreas (in press).
29. Konishi K, Tajiri H, Fujii T, Boku N, Ohtsu A, Yoshida S, Konishi M, Hasebe T, Mukai K, Makino R. Hereditary nonpolyposis colorectal cancer associated with duodenal cancer: a case report. Jpn J Clin Oncol (in press).
30. Kato K, Tajiri H, Boku N, Ishii H, Ono M, Arai T, Ryu M, Ohtsu A, Fujii T, Yoshida S. Correlation between the depth of invasion of gastric cancer and its hardness using a new ultrasound tactile sensor. Dig Endosc (in press).
Gastric Surgery Division
31. Takenaka T, Maruyama K, Kinoshita T, Sasako M, Sano T, Katai H, Matsuno Y. A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II. Br J Cancer 1997;76:1484-1488.
32. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H. Anatomical consideration of systematic lymph node dissection for gastric cancer. Asian J Surg 1997;20:112-114.
33. Sano T, Sasako M, Kinoshita T, Katai H, Maruyama K, Takenaka T, Nakanishi Y. Total gastrectomy for primary gastric lymphoma at stage IE and IIE: a prospective study of fifty cases. Surgery 1997;121:501-505.
Head & Neck Surgery Division
34. Asakage T, Nara S, Yoshizumi T, Ebihara S. Thyroglossal duct carcinoma: a case report. Jpn J Clin Oncol 1997;27:340-342.
Hepatobiliary & Pancreatic Oncology and Surgery Division
35. Iwasaki M, Furuse J, Yoshino M, Moriyama N, Kanemoto H, Okumura H. Spontaneous regression of hepatocellular carcinoma: a case report. Jpn J Clin Oncol 1997;27:278-281.
36. Ishii H, Okada S, Sato T, Wakasugi H, Saisho H, Furuse J, Ishikawa O, Matsuno S, Yokoyama S. CA 19-9 in evaluating the response to chemotherapy in advanced pancreatic cancer. Hepatogastroenterology 1997;44:279-83.
37. Furuse J, Satake M, Iwasaki M, Sekiguchi R, Moriyama N, Yoshino M. Percutaneous ethanol injection under interventional radiographic CT-fluoroscopic guidance (IVR-CT PEI) for the treatment of small hepatocellular carcinomas. Int J Clin Oncol (in press).
38. Iwasaki M, Furuse J, Yoshino M, Ryu M, Moriyama N, Mukai K. Nature of small hepatic nodules without tumor stain on computed tomography and angiography. J Clin Ultrasound (in press).
39. Ryu M, Abe Y, Nagashima T, Isono K, Ogino T. Radiotherapy for hepatocellular carcinoma. In: Livraghi T, ed. Diagnosis and Treatment of Hepatocellular Carcinoma. 29 Radiotherapy. London: Greenwich Medical Media. 1997: 395-400.
40. Tanizaki H, Ryu M, Kinoshita T, Kawano N, Konishi M, Cho A, Nakatura T, Natsume T, Takahashi S, Sugita M, Izuishi K, Yoshino M, Furuse J, Iwasaki M, Tsubono Y. Comparison of clinical features and survival in patients with hepatitis B and C virus-related hepatocellular carcinoma. Jpn J Clin Oncol 1997;27:67-70.
41. Konishi M, Ryu M, Kinoshita T, Kawano N, Tanizaki H, Cho A. Stomach-preserving gastric bypass for unresectable pancreatic cancer. Surg Today (Jpn J Surg) 1997;27:429-433.
42. Ryu M, Watanabe K, Yamamoto H, Kinoshita T, Konishi M, Kawano N. Simplified central bisegmentectomy for liver cancer. J Hep Bil Pancr Surg 1997;4:201-204.
43. Ryu M, Shimamura Y, Kinoshita T, Konishi M, Kawano N, Iwasaki M, Furuse J, Yoshino M, Moriyama N, Sugita M. Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol 1997;27:251-257.
44. Furuse J, Iwasaki M, Yoshino M, Konishi M, Kawano N, Kinoshita T, Ryu M, Satake M, Moriyama N. Hepatocellular carcinoma with portal vein tumor thrombus: embolization of arterioportal shunts. Radiology 1997;204:787-790.
45. Ryu M, Watanabe K, Yamamoto H. Hepatectomy using a microwave tissue coagulator for 99 patients with HCC. J Microw Surg 1997;15:5-11.
46. Nakatsura T, Hasebe T, Tsubono Y, Ryu M, Kinoshita T, Kawano N, Konishi M, Kosuge T, Kanai Y, Mukai K. Histological prognostic parameters for adenocarcinoma of the pancreatic head. Proposal for a scoring system for prediction of outcome. J Hep Bil Pancr Surg 1997;4:441-448.
Oncology/Hematology Division
47. Sasaki Y. Pharmacological consideration in high-dose chemotherapy. Cancer Chemother Pharmacol 1997;40(Suppl): S115-S118.
48. Takashima S, Saeki T, Adachi I, Watanabe T, Sasaki Y, Murai H, Tabei T, Ogita M, Sano M, Kanda K, Shimoyama M. A phase II study of high-dose epirubicin (EPI) plus cyclophosphamide (CPA) with G-CSF for breast cancer patients with visceral metastases or hormone-independent tumors: a trial of the Japan Clinical Oncology Group. Jpn J Clin Oncol 1997;27: 325-330.
49. Sekine I, Sasaki Y, Hasebe T, Umeda T, Mukai K. Coxalgia as the initial symptom in Hodgkin Disease: a case report. Jpn J Clin Oncol 1997;27:353-356.
50. Yuasa H, Hamajima N, Ueda R, Ohno R, Asou N, Utsunomiya A, Ogura M, Takigawa N, Ueda T, Hiraoka A, Matsuda S, Kuraishi Y, Nishikawa K, Uike N, Takeshita A, Takemoto Y, Shimazaki C, Sakamaki H, Ino T, Matsushima T, Kuriyama K, Hirai H, Naoe T, Tsubaki K, Takahashi M, Takeyama K, Morishima Y, Itoh K, Omoto E, Hodohara K, Takahashi I. Case control study of leukemia and diagnostic radiation exposure. Int J Hematol 1997; 65:251-261.
51. Itoh K, Sasaki Y, Fujii H, Ohtsu T, Wakita H, Igarashi T, Abe K. Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations. Br J Cancer 1997;76:107-113.
52. Ohtsu T, Fujii H, Wakita H, Igarashi T, Itoh K, Imoto S, Kohagura M, Sasaki Y. Pharmacokinetic study of low- versus high-dose medroxyprogesterone acetate (MPA) in women. Cancer Chemother Pharmacol (in press).
53. Minami H, Ando Y, Saka H, Shimokata K. Prediction of carboplatin clearance from standard morphological and biological patient characteristics. J Natl Cancer Inst 1997;89:968-969.
54. Ando Y, Minami H, Saka H, Ando M, Sakai S, Shimokata S. Adjustment of creatinine clearance improves accuracy of Calverti's formula for carboplatin dosing. Br J Cancer 1997;76:1067-1071.
55. Ando Y, Minami H, Saka H, Ando M, Sugiura S, Sakai S, Shimokata K. Pharmacokinetic study of carboplatin given on a 5-day intravenous schedule. Jpn J Cancer Res 1997;88:517-521.
56. Sugiura S, Ando Y, Minami H, Ando M, Sakai S, Shimokata K. Prognostic value of pleural effusion in patients with non-small cell lung cancer. Clin Cancer Res 1997;3:47-50.
Palliative Care and Psychiatric Service
57. Kagaya A, Uchitomi Y, Fukue M, Tsukano K, Kugaya A, Minagawa H, Takebayashi M, Zensho H, Oyamada T, Yamawaki S. Plasma levels of cyclic GMP, immune parameters and depressive status during interferon therapy: a prospective study in Japan. Neuropsychobiology 1997;35:128-131.
58. Okamura H, Oomori N, Uchitomi Y. An acutely confused 15-year-old girl. Lancet 1997;350: 488.
59. Uchitomi Y, Yamawaki S. Truth-telling practice in cancer care in Japan. Ann N Y Acad Sci 1997;809:290-299.
Plastic & Reconstructive Surgery Division
63. Kimata Y, Mukouda M, Mizuo H, Harii K. Second toe plantar flap for partial finger reconstruction. Plast Reconstr Surg 1998;101:101-106.
64. Kimata Y, Uchiyama K, Ebihara S, Yoshizumi T, Asai M, Saikawa M, Hayashi R, Jitsuiki Y, Majima K, Ohyama W, Haneda T, Nakatsuka T, Harii K. Versatility of the free anterolateral thigh flap for reconstruction of head and neck defects. Arch Otolarnygol Head Neck Surg (in press).
65. Kimata Y, Uchiyama K, Ebihara S, Asai M, Saikawa M, Hayashi R, Ohyama W, Haneda T, Nakatsuka T, Harii K. A new concept and technique for reconstruction of the lower pharyngeal space using the free jejunal graft. Arch Otolarnygol Head Neck Surg (in press).
Radiation Oncology Division
66. Ogino T, Murayama S, Moriyama N, Ikeda H, Yoshida S, Ebihara S. A progress report for the proton treatment facility at NCC, Kashiwa, Japan. Particles 1997;20:9-11.
67. Murayama S, Ogino T, Ikeda H, Moriyama N, Yoshida S, Ebihara S, Kakizoe T. New proton facility at the National Cancer Center Hospital East: Kashiwa project. In: Amaldi U, Larsson B, Lemoigne Y, eds. Advances in Hadrontherapy. Amsterdam: Elsevier. 1997:220-222.
68. Ryu M, Yasuhisa A, Nagashima T, Isono K, Ogino T. Diagnosis and treatment of hepatocellular carcinoma. In: Livraghi T, Makuuchi M, Buscarini L, eds. Radiotherapy. London: Greenwich Medical Media. 1997:393-400.
69. Kawashima M, Tokuuye K, Sumi M, Kagami Y, Murayama S, Nakayama H, Imai A, Ando K, Ikeda H. Radiotherapy for hepatocellular carcinoma: regarding solitary tumor on radiographic examinations. J Jpn Soc Ther Radiol Oncol 1997;9:177-186.
70. Tokuuye K, Sumi M, Ikeda H, Kagami Y, Murayama S, Nakayama H, Kawashima M, Ishii H. Technical considerations for fractionated stereotactic radiotherapy of hepatocellular carcinoma. Jpn J Clin Oncol 1997;27:170-173.
71. Tokuuye K, Akine Y, Sumi M, Kagami Y, Ikeda H, Kaneko A. Fractionated stereotactic radiotherapy for choroidal melanoma. Radiother Oncol 1997;3:87-91.
72. Ishii H, Okada S, Tokuuye K, Nose H, Okusaka T, Yoshimori M, Nagahama H, Sumi M, Kagami Y, Ikeda H. Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma. Cancer 1997;79:1516-1520.
73. Koizumi M, Inoue T, Inoue T, Yamazaki H, Tang JT, Kagawa K, Murayama S, Nose T, Tanaka E, Shiomi H. Brachytherapy three-dimensional simulation modelling in clinical practice. Curr Oncol 1997;4:36-38.
74. Fukushima S, Ozeki S, Tang JT, Koizumi M, Matsumura S, Inoue T, Inoue T, Yamazaki H, Murayama S, Hatanaka K, Ejiri H, Kasai K. Induction of p53 protein by carbon-ion and proton beam irradiation in two close human lymphoblastoid cell lines with different p53 status. Oncol Rep 1997;4:481-484.
75. el-Baradie M, Inoue T, Inoue T, Murayama S, Tang JT, Yamazaki H, Fournier-Bidoz N. HDR and MDR intracavitary treatment for carcinoma of the uterine cervix. A prospective randomized study. Strahlenther Onkol 1997;173:155-162.
Thoracic Oncology and Thoracic Surgery Divisions
76. Oshita F, Noda K, Nishiwaki Y, Fujita A, Kurita Y, Nakabayashi T, Tobise K, Abe S, Suzuki S, Hayashi I, Kawakami Y, Matsuda T, Tsuchiya S, Takahashi S, Tamura T, Saijo N. Phase II study of irinotecan and etoposide in patients with metastatic non-small-cell lung cancer. J Clin Oncol 1997;15:304-309.
77. Fukuoka M, Masuda N, Negoro S, Matsui K, Kudoh S, Kusuniki Y, Takada M, Kawahara M, Ogawara M, Kodama N, Kubota K, Furuse K. CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer. Br J Cancer 1997;75:306-309.
78. Furuse K, Kamimori T, Kawahara M, Kodama N, Ogawara M, Atagi S, Naka N, Akira M, Kubota K. A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-small-cell lung cancer with brain metastasis. Br J Cancer 1997;75:614-618.
79. Kawahara M, Fukuoka M, Saijo N, Nishiwaki Y, Ikegami H, Tamura T, Shimoyama M, Suemasu K, Furuse K. Prognostic factors and prognostic staging system for small cell lung cancer. Jpn J Clin Oncol 1997;27:158-165.
80. Imoto S, Kitaya T, Kodama T, Hasebe T, Mukai K. Idiopathic granulomatous mastitis: case report and review of the literature. Jpn J Clin Oncol 1997;27:274-277.
81. Nishimura M, Kodama T, Nishiyama H, Nishiwaki Y, Yokose T, Shimosato Y. A case of sarcomatoid carcinoma of the thymus. Pathol Int 1997;47:260-263.
82. Kubota K, Nishiwaki Y, Kakinuma R, Hojo F, Matsumoto T, Ohmatsu H, Sekine I, Yokozaki M, Goto K, Ebi N, Kodama T. Dose-intensive weekly chemotherapy for treatment of relapsed small-cell lung cancer. J Clin Oncol 1997;15:292-296.
83. Suzuki K, Nagai K, Yoshida J, Yokose T, Kodama T, Takahashi K, Nishimura M, Kawasaki N, Yokozaki M, Nishiwaki Y. The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia. Cancer 1997;79:1521-1526.
84. Sekine I, Nishiwaki Y, Kakinuma R, Kubota K, Hojo F, Matsumoto T, Ohmatsu H, Yokozaki M, Goto K, Miyamoto T, Takafuji J, Kodama T. Phase II study of high-dose dexamethasone-based association in acute and delayed high-dose cisplatin-induced emesis -JCOG study 9413. Br J Cancer 1997;76:90-92.
85. Sekine I, Yokose T, Ogura T, Suzuki K, Nagai K, Kodama T, Mukai K, Nishiwaki Y, Esumi H. Microsatellite instability in lung cancer patients 40 years of age or younger. Jpn J Cancer Res 1997;88:559-563.
86. Sekine I, Abe N, Tsugane S, Nagai K, Suzuki K, Kodama T, Nishiwaki Y, Ogura T, Esumi H. Does smoking or family history influence the prognosis of patients with non-small cell lung cancer? Oncol Rep 1997;4:1221-1227.
87. Guang SG, Ogura T, Sekine I, Yokozaki M, Esumi H, Kodama T, Nagai K. Association between p53 mutation and clinicopathological features of non-small cell lung cancer. Jpn J Clin Oncol 1997;27:211-215.
88. Yokozaki M, Nawano S, Nagai K, Moriyama N, Kodama T, Nishiwaki Y. Cine magnetic resonance imaging, computed tomography and ultrasonography in the evaluation of chest wall invasion of lung cancer. Hiroshima J Med Sci 1997;46:61-66.
89. Ebi N, Kubota K, Nishiwaki Y, Hojo F, Matsumoto T, Kakinuma R, Ohmatsu H, Sekine I, Yokosaki M, Gotoh K, Yamamoto H, Kodama T. Second-line chemotherapy for relapsed small cell lung cancer. Jpn J Clin Oncol 1997;27:166-169.
90. Ando M, Eguchi K, Shinkai T, Tamura T, Ohe Y, Yamamoto N, Kurata T, Kasai T, Ohmatsu H, Kubota K, Sekine I, Hojo F, Matsumoto T, Kodama T, Kakinuma R, Nishiwaki Y, Saijo N. Phase I study of sequentially administered topoisomerase I inhibitor (irinotecan) and topoisomerase II inhibitor (etoposide) for metastatic non-small-cell lung cancer. Br J Cancer 1997;76:1494-1499.